Pathogenic Bacteria Associated with Cholecystitis: A Review Article

  • Home
  • Pathogenic Bacteria Associated with Cholecystitis: A Review Article

Pathogenic Bacteria Associated with Cholecystitis: A Review Article

1Suhad Adnan Hassan, 2Solav A. AL Bakery, 3Zina Bakir Al-Hilli, 4Ali A. Al-fahham
1College of Medical Science, National University of Science and Technology, Iraq
2Hammurabi College of Medicine, University of Babylon, Babylon, Iraq
3Department of Microbiology, College of Veterinary Medicine, Al-Qasim Green University, Babylon, 51013, Iraq
4Faculty of Nursing, University of Kufa


ABSTRACT:

Cholecystitis is defined as an inflammation of the gallbladder. It is of major concern because if left untreated, it can progress to complex pathologies. The high burden of cholecystitis underlines the importance of epidemiological knowledge regarding its prevalence, risk factors, and related comorbid conditions for proper planning of preventive and therapeutic measures. This literature review presents recent insights into the bacteria causing cholecystitis, the problem of multidrug resistance, and the hypothetical effect of the gut microbiome on the health of the gallbladder.


REFERENCES :

1) Ahmadi, B.., Alimohammadian, Masoomeh., Yaseri, M.., Majidi, A.., Boreiri, Majid., Islami, F.., Poustchi, H.., Derakhshan, M.., Feizesani, Akabar., Pourshams, A.., Abnet, C.., Brennan, Paul., Dawsey, S.., Kamangar, F.., Boffetta, P.., Sadjadi, A.., & Malekzadeh, R.. (2016). Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran. Medicine , 95 . http://doi.org/10.1097/MD.0000000000002756 
2) Ananthakrishnan, A.. (2015). Epidemiology and risk factors for IBD. Nature Reviews Gastroenterology &Hepatology , 12 , 205-217 . http://doi.org/10.1038/nrgastro.2015.34
3) Chong, Jasmine., Liu, Peng., Zhou, Guangyan., & Xia, J.. (2020). Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nature Protocols , 15 , 799 – 821 . http://doi.org/10.1038/s41596-019-0264-1
4) Clemente, J.., Manasson, J.., & Scher, J.. (2018). The role of the gut microbiome in systemic inflammatory disease. British Medical Journal , 360 . http://doi.org/10.1136/bmj.j5145
5) Dehlin, M.., Jacobsson, L.., & Roddy, E.. (2020). Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nature Reviews Rheumatology , 16 , 380-390 . http://doi.org/10.1038/s41584-020-0441-1
6) Dhariwal, A.., Chong, Jasmine., Habib, Salam., King, Irah L.., Agellon, L.., & Xia, J.. (2017). MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Research , 45 , W180 – W188 . http://doi.org/10.1093/nar/gkx295
7) Exner, M.., Bhattacharya, S.., Christiansen, B.., Gebel, J.., Goroncy-Bermes, P.., Hartemann, P.., Heeg, P.., Ilschner, C.., Kramer, A.., Larson, E.., Merkens, W.., Mielke, M.., Oltmanns, P.., Ross, B.., Rotter, M.., Schmithausen, R.., Sonntag, H.., & Trautmann, M.. (2017). Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?. GMS Hygiene and Infection Control , 12 . http://doi.org/10.3205/dgkh000290
8) Franzosa, E.., Sirota-Madi, Alexandra., Ávila-Pacheco, J.., Fornelos, Nadine., Haiser, Henry J.., Reinker, S.., Vatanen, T.., Hall, A. B.., FASA, Himel Mallick, PhD,., McIver, L.., Sauk, J.., Wilson, R.., Stevens, B.., Scott, Justin., Pierce, K.., Deik, A.., Bullock, Kevin., Imhann, F.., Porter, Jeffrey A.., Zhernakova, A.., Fu, Jingyuan., Weersma, R.., Wijmenga, C.., Clish, C.., Vlamakis, H.., Huttenhower, C.., & Xavier, R.. (2018). Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nature microbiology , 4 , 293 – 305 . http://doi.org/10.1038/s41564-018-0306-4
9) Freifeld, A.., Bow, E.., Sepkowitz, K.., Boeckh, M.., Ito, J.., Mullen, C.., Raad, I.., Rolston, K.., Young, Jo-Anne H.., & Wingard, J.. (2011). Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 52 4 , e56-93 . http://doi.org/10.1093/cid/cir073
10) He, Yan., Wu, Wei., Zheng, Huimin., Li, Pan., McDonald, Daniel., Sheng, Hua-fang., Chen, Muxuan., Chen, Zi-hui., Ji, G.., Zheng, Zhong-Dai-Xi., Mujagond, Prabhakar., Chen, Xiao-Jiao., Rong, Zu-hua., Chen, Peng., Lyu, Li-Yi., Wang, Xian., Wu, Chong-Bin., Yu, Nan., Xu, Yanfang., Yin, Jia., Raes, J.., Knight, R.., Ma, W.., & Zhou, Hong-Wei. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine , 24 , 1532 – 1535 . http://doi.org/10.1038/s41591-018-0164-x
11) Hicks, C.., & Selvin, E.. (2019). Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Current Diabetes Reports , 19 . http://doi.org/10.1007/s11892-019-1212-8
12) Hills, Ronald D., Pontefract, Benjamin A., Mishcon, Hillary R.., Black, C.., Sutton, S. C.., & Theberge, Cory R.. (2019). Gut Microbiome: Profound Implications for Diet and Disease. Nutrients , 11 . http://doi.org/10.1159/000523712
13) Holt‐Lunstad, J.. (2017). The Potential Public Health Relevance of Social Isolation and Loneliness: Prevalence, Epidemiology, and Risk Factors. Public Policy & Aging Report , 27 , 127–130 . http://doi.org/10.1093/ppar/prx030
14) Huang, Daniel Q.., El‐Serag, H.., & Loomba, R.. (2020). Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology , 18 , 223 – 238 . http://doi.org/10.1038/s41575-020-00381-6
15) Jie, Zhuye., Xia, Huihua., Zhong, Shi-long., Feng, Q.., Li, Shenghui., Liang, Suisha., Zhong, Huanzi., Liu, Zhipeng., Gao, Yuan., Zhao, Hui., Zhang, Dongya., Su, Zheng., Fang, Zhiwei., Lan, Zhou., Li, Junhua., Xiao, L.., Li, Jun., Li, Ruijun., Li, Xiaoping., Li, Fei., Ren, Huahui., Huang, Y.., Peng, Yangqing., Li, Guanglei., Wen, Bo., Dong, Bo., Chen, Ji-yan., Geng, Qing-shan., Zhang, Zhiwei., Yang, Huanming., Wang, Jian., Wang, Jun., Zhang, Xuan., Madsen, L.., Brix, S.., Ning, G.., Xu, Xun., Liu, Xin., Hou, Yong., Jia, Huijue., He, K.., & Kristiansen, K.. (2017). The gut microbiome in atherosclerotic cardiovascular disease. Nature Communications , 8 . http://doi.org/10.1038/s41467-017-00900-1
16) Johnson, Jethro S.., Spakowicz, Daniel J.., Hong, B.., Petersen, Lauren M.., Demkowicz, Patrick C.., Chen, Lei., Leopold, Shana R.., Hanson, B.., Agresta, Hanako., Gerstein, M.., Sodergren, E.., & Weinstock, G.. (2019). Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nature Communications , 10 . http://doi.org/10.1038/s41467-019-13036-1
17) Kawamoto, Shimpei., Maruya, M.., Kato, Lucia M.., Suda, W.., Atarashi, K.., Doi, Yasuko., Tsutsui, Yumi., Qin, Hongyan., Honda, K.., Okada, T.., Hattori, M.., & Fagarasan, S.. (2014). Foxp3(+) T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis.. Immunity , 41 1 , 152-65 . http://doi.org/10.1016/j.immuni.2014.05.016
18) Keski-Rahkonen, A.., & Mustelin, L.. (2016). Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Current Opinion in Psychiatry , 29 , 340–345 . http://doi.org/10.1097/YCO.0000000000000278
19) Kho, Z. Y.., & Lal, S.. (2018). The Human Gut Microbiome – A Potential Controller of Wellness and Disease. Frontiers in Microbiology , 9 . http://doi.org/10.3389/fmicb.2018.01835
20) Klein, A.. (2021). Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nature Reviews Gastroenterology & Hepatology , 18 , 493 – 502 . http://doi.org/10.1038/s41575-021-00457-x
21) Kuo, C.., Grainge, M.., Zhang, Weiya., & Doherty, M.. (2015). Global epidemiology of gout: prevalence, incidence and risk factors. Nature Reviews Rheumatology , 11 , 649-662 . http://doi.org/10.1038/nrrheum.2015.91
22) LaSarre, Breah., & Federle, Michael J.. (2013). Exploiting Quorum Sensing To Confuse Bacterial Pathogens. Microbiology and Molecular Biology Reviews , 77 , 73 – 111 . http://doi.org/10.1128/MMBR.00046-12
23) Leon, Benjamin., & Maddox, T.. (2015). Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.. World journal of diabetes , 6 13 , 1246-58 . http://doi.org/10.4239/wjd.v6.i13.1246
24) Liu, Yong-xin., Qin, Yuan., Chen, Tong., Lu, Meiping., Qian, Xubo., Guo, Xiaoxuan., & Bai, Yang. (2020). A practical guide to amplicon and metagenomic analysis of microbiome data. Protein & Cell , 12 , 315 – 330 . http://doi.org/10.1007/s13238-020-00724-8
25) Lynch, S.., & Pedersen, Oluf. (2016). The Human Intestinal Microbiome in Health and Disease.. The New England journal of medicine , 375 24 , 2369-2379 . http://doi.org/10.1056/NEJMRA1600266
26) Magiorakos, A.., Srinivasan, A.., Carey, R.., Carmeli, Y.., Falagas, M.., Falagas, M.., Giske, C.., Harbarth, S.., Hindler, J.., Kahlmeter, G.., Olsson-liljequist, B.., Paterson, D.., Rice, L.., Stelling, J.., Struelens, M.., Vatopoulos, A.., Weber, J.., & Monnet, D.. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases , 18 3 , 268-81 . http://doi.org/10.1111/j.1469-0691.2011.03570.x
27) Manor, Ohad., Dai, C.., Kornilov, S.., Smith, Brett., Price, N.., Lovejoy, J.., Gibbons, S.., & Magis, A.. (2020). Health and disease markers correlate with gut microbiome composition across thousands of people. Nature Communications , 11 . http://doi.org/10.1038/s41467-020-18871-1
28) McMurdie, Paul J.., & Holmes, S.. (2013). phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data. PLoS ONE , 8 . http://doi.org/10.1371/journal.pone.0061217
29) Mitchell, A.., Almeida, Alexandre., Beracochea, Martin., Boland, M.., Burgin, Josephine., Cochrane, G.., Crusoe, M.., Kale, Varsha., Potter, Simon C.., Richardson, Lorna J.., Sakharova, Ekaterina A.., Scheremetjew, Maxim., Korobeynikov, A.., Shlemov, Alexander., Kunyavskaya, Olga., Lapidus, A.., & Finn, R.. (2019). MGnify: the microbiome analysis resource in 2020. Nucleic Acids Research , 48 , D570 – D578 . http://doi.org/10.1093/nar/gkz1035
30) Nutten, S.. (2015). Atopic Dermatitis: Global Epidemiology and Risk Factors. Annals of Nutrition and Metabolism , 66 , 8 – 16 . http://doi.org/10.1159/000370220
31) Ramasamy, Dhamodharan., Mishra, A.., Lagier, J.., Padhmanabhan, Roshan., Rossi, Morgane., Sentausa, E.., Raoult, D.., & Fournier, P.. (2014). A polyphasic strategy incorporating genomic data for the taxonomic description of novel bacterial species.. International journal of systematic and evolutionary microbiology , 64 Pt 2 , 384-91 . http://doi.org/10.1099/ijs.0.057091-0
32) Ren, Z.., Li, Ang., Jiang, Jianwen., Zhou, Lin., Yu, Zujiang., Lu, Haifeng., Xie, Haiyang., Chen, Xiaolong., Shao, Li., Zhang, Ruiqing., Xu, Shao-Yan., Zhang, Hua., Cui, G.., Chen, Xinhua., Sun, R.., Wen, Hao., Lerut, J.., Kan, Q.., Li, Lanjuan., & Zheng, Shusen. (2018). Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut , 68 , 1014 – 1023 . http://doi.org/10.1136/gutjnl-2017-315084
33) Riviello, E.., Kiviri, W.., Twagirumugabe, T.., Mueller, Ariel., Banner-Goodspeed, V.., Officer, Laurent., Novack, V.., Mutumwinka, M.., Talmor, D.., & Fowler, R.. (2015). Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition.. American journal of respiratory and critical care medicine , 193 1 , 52-9 . http://doi.org/10.1164/rccm.201503-0584OC
34) Rodriguez-R, Luis M.., & Konstantinidis, K.. (2014). Bypassing Cultivation To Identify Bacterial Species: Culture-independent genomic approaches identify credibly distinct clusters, avoid cultivation bias, and provide true insights into microbial species. Microbe Magazine , 9 , 111-118 . http://doi.org/10.1128/MICROBE.9.111.1
35) Romano, S.., Savva, G.., Bedarf, J.., Charles, I.., Hildebrand, F.., & Narbad, A.. (2021). Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinson’s Disease , 7 . http://doi.org/10.1038/s41531-021-00156-z
36) Schirmer, M.., Franzosa, E.., Lloyd-Price, J.., McIver, L.., Schwager, Randall., Poon, Tiffany W.., Ananthakrishnan, A.., Andrews, E.., Barron, G.., Lake, K.., Prasad, M.., Sauk, J.., Stevens, B.., Wilson, R.., Braun, J.., Denson, L.., Kugathasan, S.., McGovern, D.., Vlamakis, H.., Xavier, R.., & Huttenhower, C.. (2018). Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nature microbiology , 3 , 337 – 346 . http://doi.org/10.1038/s41564-017-0089-z
37) Skaar, Eric P.. (2010). The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts. PLoS Pathogens , 6 . http://doi.org/10.1371/journal.ppat.1000949
38) Stoll, B.., Hansen, N.., Sánchez, P.., Faix, R.., Poindexter, B.., Meurs, K. V. van., Bizzarro, M.., Goldberg, R.., Frantz, I.., Hale, E.., Shankaran, S.., Kennedy, K.., Carlo, W.., Watterberg, K.., Bell, E.., Walsh, M.., Schibler, K.., Laptook, A.., Shane, A.., Schrag, S.., Das, A.., & Higgins, R.. (2011). Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues. Pediatrics , 127 , 817 – 826 . http://doi.org/10.1542/peds.2010-2217
39) Tacconelli, E.., Cataldo, M. A.., Dancer, S.., Angelis, G. D.., Falcone, M.., Frank, U.., Kahlmeter, G.., Pan, A.., Petrosillo, N.., Rodríguez-Baño, J.., Rodríguez-Baño, J.., Singh, N.., Venditti, M.., Yokoe, D.., & Cookson, B.. (2014). ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases , 20 Suppl 1 , 1-55 . http://doi.org/10.1111/1469-0691.12427
40) Tamma, P.., Aitken, S.., Bonomo, R.., Mathers, A.., Duin, D. van., & Clancy, C.. (2021). Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 72 7 , 1109-1116 . http://doi.org/10.1093/cid/ciab295
41) Tellier, R.., Li, Yuguo., Cowling, B.., & Tang, J.. (2019). Recognition of aerosol transmission of infectious agents: a commentary. BMC Infectious Diseases , 19 . http://doi.org/10.1186/s12879-019-3707-y
42) Uhlenhopp, D.., Then, E.., Sunkara, T.., & Gaduputi, V.. (2020). Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clinical Journal of Gastroenterology , 13 , 1010 – 1021 . http://doi.org/10.1007/s12328-020-01237-x
43) Umesawa, M.., & Kobashi, G.. (2017). Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertension Research , 40 , 213-220 . http://doi.org/10.1038/hr.2016.126
44) Vogt, Nicholas M.., Kerby, R.., Dill-McFarland, Kimberly A.., Harding, Sandra., Merluzzi, A.., Johnson, Sterling C.., Carlsson, C.., Asthana, S.., Zetterberg, H.., Blennow, K.., Bendlin, B.., & Rey, F.. (2017). Gut microbiome alterations in Alzheimer’s disease. Scientific Reports , 7 . http://doi.org/10.1038/s41598-017-13601-y
45) Younossi, Z.., Anstee, Q.., Marietti, M.., Hardy, T.., Henry, L.., Eslam, M.., George, J.., & Bugianesi, E.. (2018). Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology , 15 , 11-20 . http://doi.org/10.1038/nrgastro.2017.109

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *